Deepak L Bhatt - JoVE Visualize

Showing results (1181-1190 of 1,708) with videos related to

Pageof 171

Sort By:

Circulation|January 13, 2021

Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES TrialGregory G Schwartz, Philippe Gabriel Steg, Deepak L Bhatt, et al.

Clinical Cardiology|May 27, 2021

The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)David S Eccleston, Joseph M Kim, Jurien M Ten Berg, et al.

Journal of the American Heart Association|May 27, 2021

Association Between Omega-3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and Atrial Fibrillation: MESAKaran Kapoor, Abdulhamied Alfaddagh, Mahmoud Al Rifai, et al.

Journal of the American College of Cardiology|February 21, 2019

Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary StentingFrancesco Costa, David Van Klaveren, Fausto Feres, et al.

Archives of Internal Medicine|April 12, 2006

Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital dischargePierluigi Tricoci, Matthew T Roe, Jyotsna Mulgund, et al.

Global Heart|September 2, 2022

Missed Opportunities for Screening and Management of Dysglycemia among Patients Presenting with Acute Myocardial Infarction in North India: The Prospective NORIN STEMI RegistryJohn W Ostrominski, Muthiah Vaduganathan, Meennahalli Palleda Girish, et al.

American Heart Journal Plus : Cardiology Research and Practice|April 25, 2022

Prognostic implications of serial high-sensitivity cardiac troponin testing among patients with COVID-19: A Danish nationwide registry-based cohort studyChristoffer Polcwiartek, Maria L Krogager, Mikkel P Andersen, et al.

Diabetes Care|February 6, 2025

Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized TrialGregory G Schwartz, Michael Szarek, J Wouter Jukema, et al.

JACC. Advances|February 28, 2026

Second-Generation Aldosterone Synthase Inhibitors for Hypertension: A Bayesian Meta-Analysis of Randomized TrialsFlavia Queiroga, Beatriz Araújo, André Rivera, et al.

European Heart Journal|June 1, 2026

Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impactJohny Nicolas, Angelo Oliva, Rebecca Cohen, et al.

Pageof 171

Showing results (1181-1190 of 1,708) with videos related to

Sort By:

Pageof 171

Circulation|January 13, 2021

Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES TrialGregory G Schwartz, Philippe Gabriel Steg, Deepak L Bhatt, et al.

Clinical Cardiology|May 27, 2021

The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)David S Eccleston, Joseph M Kim, Jurien M Ten Berg, et al.

Journal of the American Heart Association|May 27, 2021

Association Between Omega-3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and Atrial Fibrillation: MESAKaran Kapoor, Abdulhamied Alfaddagh, Mahmoud Al Rifai, et al.

Journal of the American College of Cardiology|February 21, 2019

Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary StentingFrancesco Costa, David Van Klaveren, Fausto Feres, et al.

Archives of Internal Medicine|April 12, 2006

Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital dischargePierluigi Tricoci, Matthew T Roe, Jyotsna Mulgund, et al.

Global Heart|September 2, 2022

Missed Opportunities for Screening and Management of Dysglycemia among Patients Presenting with Acute Myocardial Infarction in North India: The Prospective NORIN STEMI RegistryJohn W Ostrominski, Muthiah Vaduganathan, Meennahalli Palleda Girish, et al.

American Heart Journal Plus : Cardiology Research and Practice|April 25, 2022

Prognostic implications of serial high-sensitivity cardiac troponin testing among patients with COVID-19: A Danish nationwide registry-based cohort studyChristoffer Polcwiartek, Maria L Krogager, Mikkel P Andersen, et al.

Diabetes Care|February 6, 2025

Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized TrialGregory G Schwartz, Michael Szarek, J Wouter Jukema, et al.

JACC. Advances|February 28, 2026

Second-Generation Aldosterone Synthase Inhibitors for Hypertension: A Bayesian Meta-Analysis of Randomized TrialsFlavia Queiroga, Beatriz Araújo, André Rivera, et al.

European Heart Journal|June 1, 2026

Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impactJohny Nicolas, Angelo Oliva, Rebecca Cohen, et al.

Pageof 171